Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v8-FR
Language English French
Date Updated 2022-09-23 2022-09-07
Drug Identification Number 02441160 02441160
Brand name TEVA-TEMOZOLOMIDE TEVA-TEMOZOLOMIDE
Common or Proper name ACT TEMOZOLOMIDE 5MG CAPS ACT TEMOZOLOMIDE 5MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TEMOZOLOMIDE TEMOZOLOMIDE
Strength(s) 5MG 5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 50 50
ATC code L01AX L01AX
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-06-08 2022-06-08
Estimated end date 2022-09-20 2022-09-20
Actual end date 2022-09-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments